Table 2.
Characteristics | Autism Spectrum Disorder, n = 1028 1 | COVID-19, n = 20,680 1 | p-Value 2 |
---|---|---|---|
Age in Years | 12 (7.0, 16.0) | 11 (4.0, 16.0) | <0.001 |
Sex | <0.001 | ||
Female | 318 (31%) | 10,349 (50%) | |
Male | 710 (69%) | 10,331 (50%) | |
Race | <0.001 | ||
AAPINH | 43 (4.2%) | 918 (4.4%) | |
American Indian or Alaska Native | 15 (1.5%) | 270 (1.3%) | |
Black or African American | 221 (21%) | 5838 (28%) | |
Other Race | 77 (7.5%) | 1843 (8.9%) | |
White | 672 (65%) | 11,811 (57%) | |
BMI | 17 (14, 22) | 17 (14, 21) | 0.10 |
Ethnicity | <0.001 | ||
Hispanic or Latino | 181 (18%) | 4724 (23%) | |
Not Hispanic or Latino | 847 (82%) | 15,956 (77%) | |
Financial Class | <0.001 | ||
Medicaid | 487 (47%) | 7743 (37%) | |
Miscellaneous/Other | 541 (53%) | 12,937 (63%) | |
Length of Stay | 3.5 (2.0, 7.0) | 3.0 (2.0, 5.0) | <0.001 |
Started in ED | 724 (70%) | 14,489 (70%) | 0.8 |
SVI Quartile | <0.001 | ||
1 | 284 (28%) | 4413 (21%) | |
2 | 199 (19%) | 4327 (21%) | |
3 | 238 (23%) | 5056 (24%) | |
4 | 307 (30%) | 6884 (33%) |
1 Median (IQR); n (%), 2 Wilcoxon rank sum test; Pearson’s Chi-squared test.